How do I install the Endo Vitd No Screening Obesity skill?

Run npx skillmds@latest add dromlakhani/endo-vitd-no-screening-obesity in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Endo Vitd No Screening Obesity safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: makes network calls. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Endo Vitd No Screening Obesity?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Endo Vitd No Screening Obesity free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Endo Vitd No Screening Obesity?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Endo Vitd No Screening Obesity by dromlakhani

Name: Endo Vitd No Screening Obesity
Rating: 4.2 (5 reviews)
Author: dromlakhani

Endo Vitd No Screening Obesity

This skill recommends against routine 25-hydroxyvitamin D [25(OH)D] screening and subsequent vitamin D supplementation in adults with obesity when no established indication exists. It is triggered by clinician questions such as “Should I screen for vitamin D deficiency in this obese patient?” or “Is vitamin D testing indicated based on BMI?”

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Against routine vitamin D screening in obese adults

STEP 1 — Gather Information

Collect BMI to confirm obesity (BMI ≥30 kg/m²) and assess for established indications for 25(OH)D testing (e.g., hypocalcemia, malabsorption syndromes, chronic kidney disease, medications affecting vitamin D metabolism, osteoporosis, history of fractures, or falls).

STEP 2 — Rule In / Rule Out

If an established indication for 25(OH)D testing is present, proceed to evaluate per that indication; if no established indication exists, classify as obesity without indication and move to recommend against screening.

STEP 3 — Classify or Stratify

Classify the patient as either “obesity with established indication for vitamin D testing” or “obesity without established indication for vitamin D testing” based on the presence of the conditions gathered in Step 1.

STEP 4 — Decide

For patients classified as obesity without established indication, advise against routine 25(OH)D screening and empiric vitamin D supplementation; ensure adequate calcium intake and safe sun exposure to meet Dietary Reference Intakes, and consider lifestyle measures for weight management.

Clinical Guardrails / Mimics / Pitfalls

Do not screen or treat based solely on BMI; avoid ordering 25(OH)D tests incidentally in asymptomatic obese patients; do not initiate high‑dose intermittent vitamin D regimens for obesity alone; recognize that musculoskeletal pain or fatigue in obesity may have other causes and should not prompt vitamin D testing without additional clinical clues.

Concrete Clinical Example

A 52‑year‑old woman with BMI 34 kg/m² presents for routine follow‑up, denies bone pain, muscle weakness, or known malabsorption, and asks whether she should have her vitamin D level checked. The clinician advises against routine 25(OH)D screening, recommends adequate calcium and safe sun exposure per DRI, and notes that vitamin D supplementation is not indicated for obesity alone.

Source: Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290

---name: endo-vitd-no-screening-obesitydescription: This skill recommends against routine 25-hydroxyvitamin D [25(OH)D] screening and subsequent vitamin D supplementation in adults with obesity when no established indication exists. It is triggered by clinician questions such as “Should I screen for vitamin D deficiency in this obese patient?” or “Is vitamin D testing indicated based on BMI?”---# Against routine vitamin D screening in obese adults## STEP 1 — Gather InformationCollect BMI to confirm obesity (BMI ≥30 kg/m²) and assess for established indications for 25(OH)D testing (e.g., hypocalcemia, malabsorption syndromes, chronic kidney disease, medications affecting vitamin D metabolism, osteoporosis, history of fractures, or falls).## STEP 2 — Rule In / Rule OutIf an established indication for 25(OH)D testing is present, proceed to evaluate per that indication; if no established indication exists, classify as obesity without indication and move to recommend against screening.## STEP 3 — Classify or StratifyClassify the patient as either “obesity with established indication for vitamin D testing” or “obesity without established indication for vitamin D testing” based on the presence of the conditions gathered in Step 1.## STEP 4 — DecideFor patients classified as obesity without established indication, advise against routine 25(OH)D screening and empiric vitamin D supplementation; ensure adequate calcium intake and safe sun exposure to meet Dietary Reference Intakes, and consider lifestyle measures for weight management.## Clinical Guardrails / Mimics / PitfallsDo not screen or treat based solely on BMI; avoid ordering 25(OH)D tests incidentally in asymptomatic obese patients; do not initiate high‑dose intermittent vitamin D regimens for obesity alone; recognize that musculoskeletal pain or fatigue in obesity may have other causes and should not prompt vitamin D testing without additional clinical clues.## Concrete Clinical ExampleA 52‑year‑old woman with BMI 34 kg/m² presents for routine follow‑up, denies bone pain, muscle weakness, or known malabsorption, and asks whether she should have her vitamin D level checked. The clinician advises against routine 25(OH)D screening, recommends adequate calcium and safe sun exposure per DRI, and notes that vitamin D supplementation is not indicated for obesity alone.**Source:** Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290

Frequently asked questions